Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Papulosquamous skin diseases
MeSH D017444 - papulosquamous skin diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D012871:
Skin diseases
36 Companies
17 Drugs
$
Success rate
D017444:
Papulosquamous skin diseases
1 Company
1 Drug
$
Success rate
D010267:
Parapsoriasis
0 Companies
0 Drugs
Success rate
D010915:
Pityriasis
0 Companies
0 Drugs
Success rate
D011565:
Psoriasis
124 Companies
56 Drugs
$
Success rate
D012628:
Seborrheic dermatitis
85 Companies
14 Drugs
$
Success rate
D017512:
Lichenoid eruptions
1 Company
2 Drugs
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/1
Phase 3
100
%
1/1
Approved:
1
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Sandoz
Adalimumab
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use